InvestorWire NewsRoom


InvestorNewsBreaks – GC Pharma’s Promising Research, Shincheonji Church Plasma Drive Offer Ray of Hope for Latin American COVID-19 Patients
December 11, 2020

InvestorNewsBreaks – GC Pharma’s Promising Research, Shincheonji Church Plasma Drive Offer Ray of Hope for Latin American COVID-19 Patients

GC Pharma and Shincheonji Church are offering assistance for the Latin American countries ravaged by the COVID-19 pandemic. A recent breakthrough in GC Pharma’s COVID-19 research was achieved on Dec. 6, 2020, when a COVID-19 patient recovered after receiving GC Pharma’s blood plasma therapy. The therapy, GC5131, was developed by fractioning an antibody with the immunogenicity from the plasma of a recovered COVID-19 patient. Many Latin American hospitals already use GC Pharma’s IVIG-SN treatment to save patients from various illnesses, and this breakthrough may also open doors for GC Pharma’s blood plasma therapy to be administered to Latin American COVID-19 patients. In addition, Shincheonji Church provided a boost to GC Pharma’s COVID-19 treatment research through large-scale plasma donations. A total of 4,000 Shincheonji members are expected to participate in the plasma donation, which is now in its third round. “For the people around the world, [donating our blood] for a cure is the most valuable thing we can do after recovering from COVID-19,” said a member of Shincheonji Church.

To view the full press release, visit

About GC Pharma

GC Pharma, a biotechnology pioneer in South Korea, is now preparing to take another major leap forward toward ensuring a healthier and happier future for all peoples worldwide. Challenge and innovation, care and compassion, transparency and integrity, and respect and dedication are the core principles that guide GC Pharma on its journey toward achieving its next goal. For more information, visit

About Shincheonji Church

Shincheonji, Church of Jesus, the Temple of the Tabernacle of the Testimony, commonly known as Shincheonji Church, Shincheonji Church of Jesus or simply Shincheonji, is an offshoot Christian new religious movement established in South Korea by Lee Man-hee. For more information, visit

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).